Browse by category

ReShape awarded Grant to further develop Diabetes Bloc-Stim Neuromodulation device

ReShape Lifesciences has been awarded a US$300,000 Small Business Innovation Research (SBIR) grant for the development of ReShape’s...

Preoperative antihypertensive drugs and visceral fat area can predict hypertension remission and recurrence post-LSG

7 days ago

Muscle-preserving weight loss drug ASC47 plus semaglutide is superior to semaglutide monotherapy for weight loss

7 days ago

Racial and ethnic groups face barriers to obtaining OMMs

7 days ago

Weekly Digest